<ARTICLE> 5

<LEGEND>
This schedule contains summary information extracted from the Ampersand
Medical Corporation Consolidated Balance Sheet (Unaudited) for June 30,
1999 and the Consolidated Statement of Operations (Unaudited) for the Six
Months Ended June 30, 1999 and is qualified in its entirety by reference to
such financial statements.
</LEGEND>


                     
<PERIOD-TYPE>           6-MOS
<FISCAL-YEAR-END>       DEC-31-1999
<PERIOD-END>            JUN-30-1999

<CASH>                                  60
<SECURITIES>                           0
<RECEIVABLES>                          191
<ALLOWANCES>                           0
<INVENTORY>                             96
<CURRENT-ASSETS>                       528
<PP&E>                                 150
<DEPRECIATION>                          15
<TOTAL-ASSETS>                       1,989
<CURRENT-LIABILITIES>                2,494
<BONDS>                                0
<COMMON>                             1,545
<PREFERRED-MANDATORY>                  0
<PREFERRED>                            0
<OTHER-SE>                             0
<TOTAL-LIABILITY-AND-EQUITY>         1,989
<SALES>                                542
<TOTAL-REVENUES>                       542
<CGS>                                  311
<TOTAL-COSTS>                          311
<OTHER-EXPENSES>                     1,537
<LOSS-PROVISION>                       0
<INTEREST-EXPENSE>                      31
<INCOME-PRETAX>                     (1,338)
<INCOME-TAX>                           0
<INCOME-CONTINUING>                 (1,338)
<DISCONTINUED>                         0
<EXTRAORDINARY>                        0
<CHANGES>                              0
<NET-INCOME>                        (1,338)
<EPS-BASIC>                        (0.11)
<EPS-DILUTED>                        (0.11)